US · Healthcare

Brii Biosciences Limited (BRIBF)

Biotechnology

Brii Biosciences Limited (BRIBF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BRIBF

P/E ratio

25.00

Brii Biosciences Limited (BRIBF) — FAQ

What is BRIBF's P/E ratio?

The price-to-earnings (P/E) ratio for Brii Biosciences Limited (BRIBF) is 25.00 (data as of 2026-05-23).

Does Brii Biosciences Limited pay a dividend?

Dividend yield is not available in the current snapshot for Brii Biosciences Limited (BRIBF). Check the MyAverix Finance app for the latest dividend data.

What sector is Brii Biosciences Limited in?

Brii Biosciences Limited (BRIBF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BRIBF listed on?

BRIBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)